Search for: "In Re Adoption of FDS"
Results 21 - 31
of 31
Sorted by Relevance
|
Sort by Date
16 Apr 2010, 5:54 am
Dominic provides analysis of how this move potentially falls within the SEC's 2008 Regulation FD guidance and its non-exclusive factors about when web disclosure can satisfy Reg FD. [read post]
21 Feb 2024, 6:10 pm
In the proposed rule, FDA had proposed requiring manufacturers to “obtain the signature for each individual who approved or re-approved the record” (proposed § 820.35). [read post]
14 Nov 2013, 7:41 am
Ct. 2567 (2011), so we’re not going over that again. [read post]
22 Dec 2014, 11:44 am
Res. [read post]
4 Nov 2013, 9:08 am
The court adopts a position long taken by the FDA itself:The FD & C Act does not, however, limit the manner in which a physician may use an approved drug. [read post]
29 Mar 2007, 10:08 am
Roach, No. 04-004277-FD-14 (March 28, 2007). [read post]
10 Dec 2009, 6:09 am
We believe that the adoption of the rule as proposed would enhance the relati [read post]
1 Feb 2018, 5:55 pm
This culminated in the decision in In re Trulia Shareholder Litigation, 129 A.3d 884 (Del. [read post]
1 Feb 2023, 9:01 pm
Thank you Thomas [Kim] for that lovely introduction and I’m very pleased to be here at the Securities Regulation Institute giving the Alan B. [read post]
12 Oct 2006, 9:19 pm
A recent re-creation of the blog has limited the archives (the posts now only go back to September 19, 2006). [read post]
24 Apr 2009, 3:47 am
Apr. 21, 2009)Affirming dismissal of race/national origin/retaliation-discharge claims re 3 White Instrument Techs8th Circuit> Wallace v. [read post]
